Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy
Kentaro Ohuchi, Ryo Amagai, Erika Tamabuchi, Yumi Kambayashi, Taku Fujimura
Topics & Concepts
NivolumabMedicineFulminantAdjuvantVaccinationDiseaseMelanomaAdjuvant therapyImmunologyVirologyInternal medicineImmunotherapyCancerCancer researchSARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research Studies